Catapult Capital Management’s Allergan plc AGN Stock Holding History

Catapult Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$11.6M	Buy	42,500 +32,500	+325%	+$9.98M	4.37%	1
2015 Q2	$3.04M	Sell	10,000 -10,000	-50%	-$2.98M	0.44%	74
2015 Q1	$5.95M	Buy	+20,000	New	+$5.7M	0.73%	35
2014 Q4	–	Sell	-50,000	Closed	-$12.1M	–	235
2014 Q3	$12.1M	Buy	50,000 +35,000	+233%	+$7.83M	1.29%	11
2014 Q2	$3.35M	Buy	15,000 +13,092	+686%	+$2.71M	0.37%	88
2014 Q1	$393K	Sell	1,908 -95,873	-98%	-$19M	0.08%	169
2013 Q4	$16.4M	Buy	97,781 +30,696	+46%	+$4.8M	3.91%	2
2013 Q3	$9.66M	Buy	67,085 +27,085	+68%	+$3.61M	1.19%	13
2013 Q2	$5.05M	Buy	+40,000	New	+$4.53M	2.1%	4

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Catapult Capital Management's AGN Position: Q3 2015 in Review

Catapult Capital Management increased its Allergan plc (AGN) stake by 325% in Q3 2015, buying an estimated $9.98M and bringing the position to 42,500 shares worth $11.6M. The position accounts for 4.37% of the portfolio, ranked #1.

Catapult Capital Management first reported a position in AGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $16.4M in Q4 2013. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

Catapult Capital Management held 42,500 shares of Allergan plc worth $11.6M as of Q3 2015.
Catapult Capital Management bought 32,500 Allergan plc shares in Q3 2015, an estimated $9.98M.
Allergan plc made up 4.37% of Catapult Capital Management's portfolio in Q3 2015, its #1 holding.
Catapult Capital Management first reported a position in Allergan plc in Q2 2013 and has held it in 9 quarters since.
Catapult Capital Management's Allergan plc position peaked at $16.4M in Q4 2013.
1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.